These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17832207)

  • 1. Investors' Yen for U.S. Technology: From California to Massachusetts, Japanese companies are on a buying spree, snapping up U.S. high tech firms, paying huge prices for electronics and biotechnology ventures.
    Sun M
    Science; 1989 Dec; 246(4935):1238-41. PubMed ID: 17832207
    [No Abstract]   [Full Text] [Related]  

  • 2. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum.
    Science; 1989 Dec; 246(4937):1549. PubMed ID: 17834401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do investors react differently? Evidence from hospitality sector during the covid-19 pandemic.
    Tosun OK
    Financ Res Lett; 2022 Oct; 49():103099. PubMed ID: 35785405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Global Supercomputer Race for High Stakes: Although U.S. companies currently hold a lead in technology and sales, Japanese manufacturers are now producing fast machines and slashing prices.
    Sun M
    Science; 1989 Feb; 243(4894):1004-6. PubMed ID: 17734799
    [No Abstract]   [Full Text] [Related]  

  • 6. Investors' reactions and firms' actions in the Covid-19 period: The case of Taiwan.
    Hsu J; Young W; Huang YW
    Int Rev Financ Anal; 2021 Nov; 78():101905. PubMed ID: 36532658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bootstrap finance: the art of start-ups.
    Bhide A
    Harv Bus Rev; 1992; 70(6):109-17. PubMed ID: 10122688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of physician-hospital affiliations on hospital prices in California.
    Ciliberto F; Dranove D
    J Health Econ; 2006 Jan; 25(1):29-38. PubMed ID: 16352360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. California invests $300 million in high tech.
    Dalton R
    Nature; 2000 Dec; 408(6814):760. PubMed ID: 11130688
    [No Abstract]   [Full Text] [Related]  

  • 10. Industrial innovation in Japan and the United States.
    Mansfield E
    Science; 1988 Sep; 241(4874):1769-74. PubMed ID: 17783128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Best of Both Worlds: The Benefits of Open-specialized and Closed-diverse Syndication Networks for New Ventures' Success.
    Ter Wal AL; Alexy O; Block J; Sandner PG
    Adm Sci Q; 2016 Sep; 61(3):393-432. PubMed ID: 27499546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of strategic alternatives under increasing regulation in high technology companies.
    Birnbaum PH
    Acad Manage J; 1984 Sep; 27(3):489-510. PubMed ID: 10268162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everybody's doing it. With the U.S. economy limping along, the unlikeliest marketers are trying to claim a niche in healthcare.
    Becker C
    Mod Healthc; 2003 May; 33(18):4-5, 12, 1. PubMed ID: 12776664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1995: business.
    AIDS Treat News; 1995 Jan; (No 214):7. PubMed ID: 11362188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tough cell to investors. Venture capitalists are wary of investing in companies in which risks in the science may not be rewarded by a health revenue stream.
    Moran N
    Sci Am; 2005 Jul; 293(1):A32-4. PubMed ID: 16008299
    [No Abstract]   [Full Text] [Related]  

  • 16. IPOs put on hold. Medical-tech companies struggle to find investors.
    Rhea S
    Mod Healthc; 2009 Jan; 39(1):16. PubMed ID: 19230088
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood brothers. Alliances between biotechnology and pharmaceutical companies in the U.S.
    Dibner MD
    Biotechnology (N Y); 1993 Oct; 11(10):1120, 1122-3. PubMed ID: 7764092
    [No Abstract]   [Full Text] [Related]  

  • 18. Innovation. U.K.'s Royal Society ventures into funding start-up companies.
    Clery D
    Science; 2008 Mar; 319(5869):1473. PubMed ID: 18339913
    [No Abstract]   [Full Text] [Related]  

  • 19. Investors' service steps in to fill void in hospital data disclosure.
    Nemes J
    Mod Healthc; 1992 Feb; 22(5):46-7. PubMed ID: 10115940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U.S., Japanese firms team up on both sides of Pacific.
    Pallarito K
    Mod Healthc; 1990 Jun; 20(24):39. PubMed ID: 10105086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.